ask="0.7200"
ask_size="3500"
average_daily_volume="2024040"
bid="0.6000"
bid_size="100"
book_value="0.1800"
change="+0.0750"
change_from_200_day_moving_average="-1.4153"
change_from_50_day_moving_average="0.0474"
change_from_52_week_high="-4.1888"
change_From_52_week_low="0.2012"
change_in_percent="+11.7887%"
close="0.7112"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4440"
ebitda="-49.68M"
eps_estimate_current_year="-1.5900"
eps_estimate_next_quarter="-0.3300"
eps_estimate_next_year="-1.2900"
ex_dividend_date="N/A"
float_shares="36794000"
high="0.7300"
high_52_weeks="4.9000"
last_trade_date="2/15/2017"
last_trade_price="0.7112"
last_trade_size="6687"
last_trade_time="4:00pm"
low="0.6255"
low_52_weeks="0.5100"
market_capitalization="29.84M"
moving_average_200_day="2.1265"
moving_average_50_day="0.6638"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.6368"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-66.5554%"
percent_change_from_50_day_moving_average="+7.1368%"
percent_change_from_52_week_high="-85.4857%"
percent_change_from_52_week_low="+39.4510%"
previous_close="0.6362"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.5344"
price_per_sales="12.9383"
revenue="2.06M"
shares_outstanding="41955000"
short_ratio="3.7000"
stock_exchange="NGM"
symbol="ANTH"
volume="2657973"
weeks_range_52="0.5100 - 4.9000"
